Gut bacterial profile can predict gut damage following radiotherapy

Rather like a physical fingerprint, the gut microbial pattern can be used to identify certain vulnerabilities in patients who are undergoing radiation therapy for prostate or gynecologic cancer, predicting which of them are most likely to suffer damage to the intestine. The new study reporting this finding was published in the journal Clinical Cancer Research on October 2, 2019.

radiotherapy-gut-profileRoman Zaiets | Shutterstock

The human gut microbiome

The human gut contains about 37 trillion bacteria, both beneficial and potentially harmful. The effects of these bacteria, which are found at the highest concentrations in the large intestine onwards, are manifold. They vary with the person’s genetic blueprint, as well as with the type of diet that is habitually eaten.

They help to digest food and provide several vital substrates to the body, helping to handle energy inputs more efficiently and run the metabolism smoothly, for instance. In each person, the precise composition of the gut bacterial profile is just a little different from other people. However, typically the gut microbiome in humans is composed of many different species belonging to families from five major phyla.

The study

The findings came from a study in London that focused on ‘fingerprinting’ the gut microbes as well as those in fecal samples collected from 134 patients who were at various stages of radiotherapy, including some who had completed the process. The radiation was in all cases delivered to the prostate or pelvic lymph nodes. They looked mainly at the differences in the gut bacteria that existed before the start of radiotherapy, to predict the occurrence of gut damage.

Following radiation therapy to the pelvis, 80% of patients say they experience a change in bowel habits. In up to a quarter of patients, pelvic radiation damages the gut irreparably and significantly, reducing their quality of life. For example, gut damage can cause bleeding, loose stools, abdominal pain, weight loss and nausea, both early – during or just after a course of radiation therapy – or late – three or more months after the end of treatment. The researchers therefore aimed at finding associations between gut damage and such responses.

The findings

Patients who had relatively fewer species of bacteria in their gut suffered more damage to the intestinal tract, both immediately and after the end of the treatment. Also, the researchers found that when three bacterial types – Clostridium IV, Roseburia, and Phascolarctobacterium – are relatively increased by 30-50% in patients who are at a higher risk of gut damage. These patients also show a lower number of overall bacterial species. Compared to patients with post-radiation gut damage, other patients have a more diverse gut microbiome.

Moreover, such patients are thought to be more susceptible to radiation-induced damage because they need a higher number of ‘good bacteria’ to keep their gut healthy and in good shape under normal conditions. Due to this requirement for more bacteria, the inevitable reduction in overall bacterial counts that occurs with radiation promotes greater gut damage.

Once the findings of the current study are confirmed, researchers can try to minimize or perhaps even prevent such damage by treatments aimed at increasing the diversity of the gut bacteria, such as by a fecal transplant.

The importance of this study

This study is pioneering and unique in its focus: linking the protection conferred by a good gut microbiome to reduced late harm following radiotherapy. The researchers aim to go on to study the effect of fecal transplants to reduce, prevent or treat gut damage after radiation in patients with high-risk microbiomes. Another potentially beneficial intervention could be to change the radiation fractions used in this group.

Our study is the first to show that gut bacteria have an important influence on how susceptible patients are to gastrointestinal side effects from radiotherapy. If we can identify patients at the highest risk of gut damage we could intervene to control, treat or even prevent the side effects of radiation.”

Researcher David Dearnaley

Source:

Gut bacteria ‘fingerprint’ predicts radiotherapy side effects. The Institute of Cancer Research. https://www.icr.ac.uk/news-archive/gut-bacteria-fingerprint-predicts-radiotherapy-side-effects

Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2019, October 03). Gut bacterial profile can predict gut damage following radiotherapy. News-Medical. Retrieved on December 26, 2024 from https://www.news-medical.net/news/20191003/Gut-bacterial-profile-can-predict-gut-damage-following-radiotherapy.aspx.

  • MLA

    Thomas, Liji. "Gut bacterial profile can predict gut damage following radiotherapy". News-Medical. 26 December 2024. <https://www.news-medical.net/news/20191003/Gut-bacterial-profile-can-predict-gut-damage-following-radiotherapy.aspx>.

  • Chicago

    Thomas, Liji. "Gut bacterial profile can predict gut damage following radiotherapy". News-Medical. https://www.news-medical.net/news/20191003/Gut-bacterial-profile-can-predict-gut-damage-following-radiotherapy.aspx. (accessed December 26, 2024).

  • Harvard

    Thomas, Liji. 2019. Gut bacterial profile can predict gut damage following radiotherapy. News-Medical, viewed 26 December 2024, https://www.news-medical.net/news/20191003/Gut-bacterial-profile-can-predict-gut-damage-following-radiotherapy.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adding SBRT to sorafenib improves survival in hepatocellular carcinoma patients